Search Results - "Nembo, Blandine"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Safety, tolerability and pharmacokinetics of oral venglustat in Parkinson’s disease patients with a GBA mutation (S4.002)

    Safety, tolerability and pharmacokinetics of oral venglustat in Parkinson’s disease patients with a GBA mutation (S4.002) by Fischer, Tanya, Gasser, Thomas, Isaacson, Stuart, Kulisevsky, Jaime, Mir, Pablo, Simuni, Tanya, Wills, Anne Marie, Guedes, Leonor Correia, Svenningsson, Per, Waters, Cheryl, Ji, Allena, Li, Jian, Minini, Pacal, Nembo, Blandine, Sardi, S. Pablo, Saubadu, Stéphane, Sharma, Jyoti, Peterschmitt, M. Judith

    Published in Neurology (09-04-2019)
    “…Abstract only…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in the Japanese and the Rest of the World Parkinson’s Disease Population With a GBA Mutation: Results from Part 1 of the MOVES-PD Study (809)

    Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in the Japanese and the Rest of the World Parkinson’s Disease Population With a GBA Mutation: Results from Part 1 of the MOVES-PD Study (809) by Peterschmitt, M. Judith, Saiki, Hidemoto, Hatano, Taku, Gasser, Thomas, Isaacson, Stuart, Kulisevsky, Jaime, Simuni, Tanya, Takahashi, Yuji, Wills, Anne-Marie, Guedes, Leonor Correia, Svenningsson, Per, Takahashi, Ryosuke, Waters, Cheryl, Katsuno, Masahisa, Ji, Allena Ji, Gaemers, Sebastiaan J. M., Minini, Pascal, Nembo, Blandine, Sardi, Pablo, Saubadu, Stéphane, Sharma, Jyoti, Fischer, Tanya

    Published in Neurology (14-04-2020)
    “…Abstract only…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    Safety, tolerability and pharmacokinetics of oral venglustat in Parkinson disease patients with a GBA mutation

    Safety, tolerability and pharmacokinetics of oral venglustat in Parkinson disease patients with a GBA mutation by Judith Peterschmitt, M., Gasser, Thomas, Isaacson, Stuart, Kulisevsky, Jaime, Mir, Pablo, Simuni, Tanya, Wills, Anne-Marie, Guedes, Leonor Correia, Svenningsson, Per, Waters, Cheryl, Ji, Allena J., Li, Jian, Minini, Pascal, Nembo, Blandine, Saubadu, Stéphane, Sharma, Jyoti, Fischer, Tanya

    Published in Molecular genetics and metabolism (01-02-2019)
    “…Mutations in GBA are associated with increased risk of developing Parkinson disease (PD), characterized by younger onset, higher prevalence of cognitive…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    Safety, pharmacokinetics, and pharmacodynamics of oral venglustat in Parkinson disease patients with a GBA mutation from Japan and the rest of the world: Results from part 1 of the MOVES-PD study

    Safety, pharmacokinetics, and pharmacodynamics of oral venglustat in Parkinson disease patients with a GBA mutation from Japan and the rest of the world: Results from part 1 of the MOVES-PD study by Peterschmitt, M. Judith, Saiki, Hidemoto, Hatano, Taku, Gasser, Thomas, Isaacson, Stuart, Kulisevsky, Jaime, Simuni, Tanya, Takahashi, Yuji, Wills, Anne-Marie, Guedes, Leonor Correia, Svenningsson, Per, Takahashi, Ryosuke, Waters, Cheryl, Katsuno, Masahisa, Ji, Allena Ji, Gaemers, Sebastiaan J.M., Minini, Pascal, Nembo, Blandine, Sardi, Pablo, Saubadu, Stéphane, Sharma, Jyoti, Fischer, Tanya

    Published in Molecular genetics and metabolism (01-02-2020)
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: